No CapEx as the Fast MDx platform is lent as part of the low cost test contract

No packaging cost

No transportation costs

No Biosecure lab overheads

Single technician operation

Faster Results
Earlier treatment
Better outcomes

Reduced spread of infectious disease

1000+ Patient
test results per 8 hour shift

5 times more efficent than manual test processing

Near-Patient
eliminates transportation
and packaging

The NGx2
Ultra-Fast qPCR
thermal cycle minimizes
electrical use

Fully automated
optimized sample processing reduces
handling errors and the need to retest